IRIS
VAGAGGINI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.930
NA - Nord America 1.575
AS - Asia 1.538
SA - Sud America 261
Continente sconosciuto - Info sul continente non disponibili 147
AF - Africa 68
OC - Oceania 7
Totale 5.526
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.480
IT - Italia 764
RU - Federazione Russa 547
SG - Singapore 498
CN - Cina 385
BR - Brasile 213
VN - Vietnam 190
IE - Irlanda 123
KR - Corea 112
BD - Bangladesh 99
HK - Hong Kong 98
DE - Germania 92
FR - Francia 77
GB - Regno Unito 67
IN - India 62
FI - Finlandia 43
SE - Svezia 38
NL - Olanda 37
MX - Messico 35
ZA - Sudafrica 35
CA - Canada 33
ES - Italia 25
PL - Polonia 25
AT - Austria 14
CZ - Repubblica Ceca 14
JP - Giappone 14
KE - Kenya 14
AR - Argentina 13
JM - Giamaica 11
EC - Ecuador 10
IQ - Iraq 10
GR - Grecia 9
UA - Ucraina 9
IR - Iran 8
PK - Pakistan 8
AU - Australia 7
PT - Portogallo 7
TR - Turchia 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
ID - Indonesia 6
MA - Marocco 6
LI - Liechtenstein 5
PY - Paraguay 5
VE - Venezuela 5
CH - Svizzera 4
CL - Cile 4
CO - Colombia 4
HN - Honduras 4
PH - Filippine 4
SA - Arabia Saudita 4
TN - Tunisia 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EG - Egitto 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
NO - Norvegia 3
PE - Perù 3
RO - Romania 3
UY - Uruguay 3
AM - Armenia 2
DK - Danimarca 2
KG - Kirghizistan 2
LV - Lettonia 2
RS - Serbia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
TT - Trinidad e Tobago 1
Totale 5.380
Salva come PNG Salva come JPEG
Città #
Singapore 323
San Jose 221
Dallas 215
Milan 206
Hefei 165
Moscow 159
Ashburn 127
Santa Clara 126
Dublin 122
Siena 120
Seoul 109
Council Bluffs 107
Hong Kong 93
Beijing 73
Florence 71
New York 62
Ho Chi Minh City 60
Los Angeles 55
Rome 54
Lauterbourg 41
Hanoi 39
The Dalles 35
Johannesburg 31
Munich 31
São Paulo 28
Bengaluru 26
Lappeenranta 25
Buffalo 22
Columbus 22
Chicago 21
Orem 19
Frankfurt am Main 17
Amsterdam 15
Boardman 15
Warsaw 15
Da Nang 14
Nuremberg 14
Mexico City 13
Montreal 13
Naples 13
Turin 13
London 12
Portsmouth 12
Tokyo 12
Figino 11
Helsinki 11
Stockholm 11
Belo Horizonte 10
Prato 10
Redondo Beach 10
Salt Lake City 10
Toronto 10
Bologna 9
Brasília 9
Brno 9
Chandler 9
Düsseldorf 9
Haiphong 9
Poplar 9
Vienna 9
Brescia 8
Brooklyn 8
Dhaka 8
Kingston 8
Paris 8
Shanghai 8
Atlanta 7
Calci 7
Guayaquil 7
Hải Dương 7
Manchester 7
New Delhi 7
Querétaro 7
Rio de Janeiro 7
Boston 6
Lisbon 6
Newark 6
Phoenix 6
Piscataway 6
Bari 5
Chennai 5
Guangzhou 5
L’Aquila 5
Oxford 5
Santo André 5
Ankara 4
Barnet 4
Caldes de Montbui 4
Denver 4
Duhok 4
Houston 4
Jacksonville 4
Leipzig 4
Mumbai 4
Nairobi 4
Palermo 4
Philadelphia 4
Pune 4
Rimini 4
Seattle 4
Totale 3.365
Salva come PNG Salva come JPEG
Nome #
Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth 272
A Facile Access to Green Fluorescent Albumin Derivatives 249
Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents 221
Light-mediated activation/deactivation control and in vitro ADME-Tox profiling of a donepezil-like Dual AChE/MAO-B Inhibitor 217
Characterization of in vitro and in vivo properties of pharmacologically active compounds in a GLP-Like laboratory 217
Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents 213
Serendipitous identification of azine anticancer agents using a privileged scaffold morphing strategy 204
Development and validation of derivatization-based LC-MS/MS method for quantification of short-chain fatty acids in human, rat, and mouse plasma 189
Exploiting fall foliage by-products to optimize Tenebrio molitor nutraceutical value 187
A greener technique for microwave-assisted O-Silylation and silyl ether deprotection of uridine and other substrates 183
DEAD-Box Helicase DDX3X as a host target against emerging viruses: new insights for medicinal chemical approaches 182
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors 179
Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model 178
Efficient use of agricultural waste to naturally fortify Tenebrio molitor mealworms and evaluation of their nutraceutical properties 176
Reversible monoacylglycerol lipase inhibitors: discovery of a new class of benzylpiperidine derivatives 170
Infesting Seaweeds as a Novel Functional Food: Analysis of Nutrients, Antioxidants and ACE Inhibitory Effects 166
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme 162
Fluoromethylcarnitine, a novel inhibitor of trimethylamine levels in trimethylaminuria and trimethylamine N-oxide related disorders 161
Progress towards adjuvant development: focus on antiviral therapy 159
Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinoma 156
Sweet cherry extract as permeation enhancer of tyrosine kinase inhibitors: a promising prospective for future oral anticancer therapies 140
Use of distillery by-products as Tenebrio molitor mealworm feed supplement 140
The replacement of flour-based feed with pellets reduces dustiness and improves tenebrio molitor breeders' safety 139
Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity 137
Proteins from Tenebrio molitor: an interesting functional ingredient and a source of ACE inhibitory peptides 135
Exploitation of the Nutraceutical Potential of the Infesting Seaweed Chaetomorpha linum as a Yellow Mealworms’ Feed: Focus on Nutrients and Antioxidant Activity 130
Upcycling Milk Industry Byproducts into Tenebrio molitor Larvae: Investigation on Fat, Protein, and Sugar Composition 125
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment 124
Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study 116
Triazolo[3,4- b]benzothiazole scaffold as versatile nicotinamide mimic allowing nanomolar inhibition of different PARP enzymes 107
Insects as Source of Nutraceuticals with Antioxidant, Antihypertensive, and Antidiabetic Properties: Focus on the Species Approved in Europe up to 2024 75
Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration 72
Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment 58
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents 55
Evaluation of anti-tumoral activity in 3D cell model of a Src inhibitor prodrug for glioblastoma treatment 46
Optimization of 2,3-dihydrophthalazine-1,4-dione PARP inhibitor scaffold for nanomolar potency and specificity towards human PARP10 38
From Ecological Threat to Bioactive Resource: The Nutraceutical Components of Blue Crab (Callinectes sapidus) 30
Design, synthesis and structural mechanism of action of TRPV1 agonist MSP20 with long-lasting analgesic effect 18
Totale 5.526
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 0 0 0 4 5
2022/2023103 1 6 5 6 5 31 4 17 11 7 3 7
2023/2024386 11 13 11 25 11 53 74 17 11 23 44 93
2024/20251.307 48 30 116 101 141 65 96 98 101 74 120 317
2025/20263.355 212 383 267 406 620 133 381 108 156 229 176 284
2026/2027366 168 103 95 0 0 0 0 0 0 0 0 0
Totale 5.526